131733457	131733457	CD	B-NP	O
|	|	NN	I-NP	O
TNH	TNH	NN	I-NP	O
|	|	NN	I-NP	O
98152187	98152187	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
079856	079856	CD	B-NP	O
|	|	CC	I-NP	O
7/22/2001	7/22/2001	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Myocardial	Myocardial	NNP	I-NP	O
Infarction	Infarction	NNP	I-NP	O
|	|	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/2/2001	5/2/2001	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/16/2001	11/16/2001	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
DENTY	DENTY	NNP	B-NP	O
,	,	,	O	O
SHAUN	SHAUN	NNP	B-NP	O
W	W	NNP	I-NP	O
827-89-43-7	827-89-43-7	CD	I-NP	O
Ja	Ja	NNP	I-NP	O
St	St	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
8/6/01	8/6/01	CD	B-NP	O
AT	AT	NN	I-NP	O
04	04	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNS	B-NP	O
CODE	CODE	NN	I-NP	O
STATUS	STATUS	NNS	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ASA	ASA	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	I-NP	O
ACID	ACID	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
ATENOLOL	ATENOLOL	NNP	I-NP	O
50	50	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

PHOSLO	PHOSLO	NN	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
ACETATE	ACETATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2	2	CD	I-NP	O
,	,	,	I-NP	O
001	001	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
3	3	CD	B-NP	O
TABLETS	TABLETS	NN	I-NP	O
WITH	WITH	NN	I-NP	O
MEALS	MEALS	NN	I-NP	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
3	3	CD	B-NP	O
667mgs	667mg	NNS	I-NP	O
tablets	tablet	NNS	I-NP	O
CALCIUM	CALCIUM	NN	I-NP	O
CARBONATE	CARBONATE	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
500	500	CD	I-NP	O
MG	MG	NN	I-NP	O
ELEM	ELEM	NN	I-NP	O
.	.	.	O	O

CA	CA	NN	B-NP	O
+	+	SYM	O	O
+	+	SYM	B-NP	O
-RRB-	-RRB-	SYM	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
250	250	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
DEPAKOTE	DEPAKOTE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DIVALPROEX	DIVALPROEX	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
62.5	62.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
give	give	VB	B-VP	O
one	one	CD	B-NP	O
half	half	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
125	125	CD	I-NP	O
mg	mg	NN	I-NP	O
tablet	tablet	NN	I-NP	O
po	po	NN	I-NP	O
tid	tid	NN	I-NP	O
.	.	.	O	O

Thanks	Thank	NNS	B-NP	O
.	.	.	O	O

LISINOPRIL	LISINOPRIL	NN	B-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
NTG	NTG	NNP	I-NP	O
1/150	1/150	CD	I-NP	O
-LRB-	-LRB-	SYM	O	O
NITROGLYCERIN	NITROGLYCERIN	NN	B-NP	B-protein
1/150	1/150	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	I-NP	I-protein
0.4	0.4	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
1	1	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
Q5	Q5	NN	I-NP	I-protein
MIN	MIN	NN	I-NP	I-protein
X	X	SYM	B-NP	I-protein
3	3	CD	I-NP	I-protein
DARVOCET	DARVOCET	NN	I-NP	I-protein
N	N	NN	I-NP	I-protein
100	100	CD	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
PROPOXYPHENE	PROPOXYPHENE	NN	I-NP	I-protein
NAP	NAP	NN	I-NP	I-protein
.	.	.	O	O

/	/	SYM	O	O
ACETAMINOPHEN	ACETAMINOPHEN	NN	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
PO	PO	NN	I-NP	O
Q4H	Q4H	NN	I-NP	O
PRN	PRN	NN	I-NP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/10/01	10/10/01	CD	B-NP	O
by	by	IN	B-PP	O
FOOSE	FOOSE	NN	B-NP	O
,	,	,	O	O
CLAUD	CLAUD	NNP	B-NP	O
E.	E.	NNP	I-NP	O
POSSIBLE	POSSIBLE	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-PP	O
NARCOTICS	NARCOTICS	NNP	B-NP	O
,	,	,	O	O
DIPHENYLHEPTANE	DIPHENYLHEPTANE	NNP	B-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
takes	take	VBZ	B-VP	O
daily	daily	RB	B-ADVP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
without	without	IN	B-PP	O
adverse	adverse	JJ	B-NP	O
effects	effect	NNS	I-NP	O
Previous	Previous	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/10/01	10/10/01	CD	B-NP	O
by	by	IN	B-PP	O
MCMANEMY	MCMANEMY	NNP	B-NP	O
,	,	,	O	O
GILBERT	GILBERT	NNP	B-NP	O
J.	J.	NNP	I-NP	O
POSSIBLE	POSSIBLE	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-PP	O
NARCOTICS	NARCOTICS	NNP	B-NP	O
,	,	,	O	O
DIPHENYLHEPTANE	DIPHENYLHEPTANE	NNP	B-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
takes	take	VBZ	B-VP	O
daily	daily	RB	B-ADVP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
without	without	IN	B-PP	O
adverse	adverse	JJ	B-NP	O
effects	effect	NNS	I-NP	O
Previous	Previous	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
8/8/01	8/8/01	CD	B-NP	O
by	by	IN	B-PP	O
DRAGULA	DRAGULA	NNP	B-NP	O
,	,	,	O	O
BENEDICT	BENEDICT	NNP	B-NP	O
R.	R.	NNP	I-NP	O
POSSIBLE	POSSIBLE	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-PP	O
NARCOTICS	NARCOTICS	NNP	B-NP	O
,	,	,	O	O
DIPHENYLHEPTANE	DIPHENYLHEPTANE	NNP	B-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
patient	patient	NN	B-NP	O
takes	take	VBZ	B-VP	O
daily	daily	RB	B-ADVP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
without	without	IN	B-PP	O
adverse	adverse	JJ	B-NP	O
effects	effect	NNS	I-NP	O
TRAZODONE	TRAZODONE	NN	I-NP	B-protein
150	150	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
HS	HS	NN	I-NP	I-protein
SIMVASTATIN	SIMVASTATIN	NN	I-NP	I-protein
20	20	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QHS	QHS	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	O
instructs	instruct	NNS	I-NP	O
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

CLOPIDOGREL	CLOPIDOGREL	NN	B-NP	O
75	75	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/10/01	10/10/01	CD	B-NP	O
by	by	IN	B-PP	O
PAUKERT	PAUKERT	NN	B-NP	O
,	,	,	O	O
BRICE	BRICE	NNP	B-NP	O
C.	C.	NNP	I-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
INDOCIN	INDOCIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
87807137	87807137	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
CLOPIDOGREL	CLOPIDOGREL	NNP	B-NP	O
BISULFATE	BISULFATE	NNP	I-NP	O
&	&	CC	I-NP	O
INDOMETHACIN	INDOMETHACIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
has	have	VBZ	B-VP	O
pericarditis	pericarditis	NN	B-NP	O
CELECOXIB	CELECOXIB	NN	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
with	with	IN	B-PP	O
food	food	NN	B-NP	O
PRILOSEC	PRILOSEC	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OMEPRAZOLE	OMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
8/6/01	8/6/01	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NN	B-NP	O
SERIOUS	SERIOUS	NN	I-NP	O
INTERACTION	INTERACTION	NN	I-NP	O
:	:	:	O	O
RANITIDINE	RANITIDINE	NN	B-NP	O
HCL	HCL	NN	I-NP	O
,	,	,	O	O
ORAL	ORAL	NNP	B-NP	O
&	&	CC	I-NP	O
OMEPRAZOLE	OMEPRAZOLE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
ok	ok	NN	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	B-NP	O
2	2	CD	I-NP	O
gm	gm	NN	I-NP	O
Na	Na	NN	I-NP	O
/	/	SYM	B-NP	O
Low	Low	NN	I-NP	O
saturated	saturate	VBN	I-NP	O
fat	fat	NN	I-NP	O
;	;	:	O	O
low	low	JJ	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
/	/	SYM	B-NP	O
Renal	Renal	JJ	I-NP	O
diet	diet	NN	I-NP	O
Activity	Activity	NN	I-NP	O
-	-	HYPH	O	O
As	As	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
RETURN	RETURN	NNP	I-NP	O
TO	TO	NNP	I-NP	O
WORK	WORK	NNP	I-NP	O
:	:	:	O	O
Not	Not	NNP	B-NP	O
Applicable	Applicable	NNP	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Asch	Asch	NNP	I-NP	O
,	,	,	O	O
call	call	NN	B-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
within	within	IN	B-PP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Berroa	Berroa	NNP	I-NP	O
,	,	,	O	O
Cardiology	Cardiology	NNP	B-NP	O
,	,	,	O	O
within	within	IN	B-PP	O
four	four	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
Vancomycin	Vancomycin	NN	B-NP	O
hcl	hcl	NN	I-NP	O
,	,	,	O	O
Nephrocaps	Nephrocaps	NNP	B-NP	O
,	,	,	O	O
Codeine	Codeine	NNP	B-NP	O
,	,	,	O	O
Percocet	Percocet	NNP	B-NP	O
,	,	,	O	O
Nephrocaps	Nephrocaps	NNP	B-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Myocardial	Myocardial	NNP	B-NP	O
Infarction	Infarction	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Myocardial	Myocardial	NNP	I-NP	O
Infarction	Infarction	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
OPERATIONS	OPERATIONS	NNPS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNPS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NN	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	VBZ	B-VP	O
-LRB-	-LRB-	NNP	B-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
28y	28y	CD	B-NP	O
old	old	JJ	I-NP	O
women	woman	NNS	I-NP	O
with	with	IN	B-PP	O
ESRD	ESRD	NN	B-NP	O
from	from	IN	B-PP	O
congenital	congenital	JJ	B-NP	O
renal	renal	JJ	I-NP	O
hypoplasia	hypoplasia	NN	I-NP	O
on	on	IN	B-PP	O
HD	HD	NN	B-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	O
hx	hx	NN	I-NP	O
for	for	IN	B-PP	O
pericarditis	pericarditis	NN	B-NP	O
no	no	DT	B-NP	O
anginal	anginal	JJ	I-NP	O
or	or	CC	I-NP	O
known	know	VBN	I-NP	O
CAD	CAD	NN	I-NP	B-protein
.	.	.	O	O

Presented	Present	VBN	B-NP	O
ER	ER	NN	I-NP	B-protein
PMH	PMH	NN	I-NP	O
4/12	4/12	CD	I-NP	O
.	.	.	O	O

Treated	Treat	VBN	B-VP	O
with	with	IN	B-PP	O
NTG	NTG	NN	B-NP	O
lopressor	lopressor	NN	I-NP	O
MSO4	MSO4	NN	I-NP	O
Dilaudid	Dilaudid	VBD	B-VP	O
after	after	IN	B-PP	O
R/I	R/I	NN	B-NP	O
with	with	IN	B-PP	O
Troponin	Troponin	NN	B-NP	O
peak	peak	NN	I-NP	O
42.1	42.1	CD	B-NP	O
Cpk	Cpk	NN	I-NP	B-protein
983.6	983.6	CD	B-NP	I-protein
/	/	SYM	I-NP	O
21	21	CD	I-NP	O
Aggrastat	Aggrastat	NN	I-NP	O
started	start	VBD	B-VP	O
Cath	Cath	NNP	B-NP	O
KHO	KHO	NNP	I-NP	O
showed	show	VBD	B-VP	O
RCA	RCA	NN	B-NP	O
90	90	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
70	70	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
40	40	CD	B-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
PDA	PDA	NN	I-NP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
LAD	LAD	NN	B-NP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
65	65	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
Cx40	Cx40	NN	B-NP	B-protein
%	%	NN	I-NP	I-protein
LVHK	LVHK	NN	I-NP	I-protein
,	,	,	O	O
EF	EF	NN	B-NP	O
70	70	CD	B-NP	O
%	%	NN	I-NP	O
Transferred	Transfer	VBN	B-VP	O
to	to	TO	B-PP	O
AMC	AMC	NN	B-NP	O
cath	cath	NN	I-NP	O
Lad	Lad	NN	I-NP	O
stented	stente	VBD	B-VP	O
RCA	RCA	NN	B-NP	B-protein
,	,	,	O	O
PDA	PDA	NN	B-NP	O
to	to	TO	B-PP	O
0	0	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

8/21	8/21	CD	B-NP	O
had	have	VBD	B-VP	O
dialysis	dialysis	NN	B-NP	O
today	today	NN	B-NP	O
,	,	,	O	O
tolerating	tolerate	VBG	B-VP	O
BB	BB	NNP	B-NP	O
,	,	,	O	O
started	start	VBD	B-VP	O
Statin	Statin	NNP	B-NP	O
ACE	ACE	NNP	I-NP	O
asa	asa	NNP	I-NP	O
Plavix	Plavix	NNP	I-NP	O
ECHO	ECHO	NN	I-NP	B-protein
shows	show	VBZ	B-VP	O
mild	mild	JJ	B-NP	O
inf	inf	NN	I-NP	O
HK	HK	NN	I-NP	O
tr	tr	NN	I-NP	O
MR	MR	NN	I-NP	O
TR	TR	NN	I-NP	O
no	no	DT	B-NP	O
effusion	effusion	NN	I-NP	O
EF	EF	NN	I-NP	O
55-60	55-60	CD	B-NP	O
%	%	NN	I-NP	O
On	On	IN	B-PP	O
7/23	7/23	CD	B-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
developed	develop	VBD	B-VP	O
mild	mild	JJ	B-NP	O
hemoptysis	hemoptysis	NN	I-NP	O
and	and	CC	O	O
epigastric	epigastric	JJ	B-NP	B-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

Switched	Switched	JJ	B-NP	O
indocin	indocin	NN	I-NP	O
to	to	TO	B-PP	O
celecoxib	celecoxib	NN	B-NP	O
.	.	.	O	O

Added	Add	VBN	B-NP	O
esomeprazole	esomeprazole	NN	I-NP	O
.	.	.	O	O

PMHX	PMHX	NN	B-NP	O
:	:	:	O	O
ESRD	ESRD	NN	B-NP	O
on	on	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
due	due	JJ	B-ADVP	O
to	to	TO	B-PP	O
congenital	congenital	JJ	B-NP	O
renal	renal	JJ	I-NP	O
hypoplasia	hypoplasia	NN	I-NP	O
.	.	.	O	O

Migraines	Migraine	NNS	B-NP	O
.	.	.	O	O

seizure	seizure	NN	B-NP	O
disorder	disorder	NN	I-NP	O
.	.	.	O	O

s/p	s/p	NN	B-NP	O
renal	renal	JJ	I-NP	O
transplant	transplant	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
was	be	VBD	B-VP	O
viable	viable	JJ	B-ADJP	O
from	from	IN	B-PP	O
1991-1993	1991-1993	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

ROS	ROS	NN	B-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
bright	bright	JJ	I-NP	O
red	red	JJ	I-NP	O
blood	blood	NN	I-NP	O
per	per	IN	B-PP	O
rectum	rectum	NN	B-NP	O
,	,	,	O	O
melena	melena	NN	B-NP	O
,	,	,	O	O
loss	loss	NN	B-NP	O
of	of	IN	B-PP	O
consciousness	consciousness	NN	B-NP	O
,	,	,	O	O
diziness	diziness	NN	B-NP	O
,	,	,	O	O
heat	heat	NN	B-NP	O
or	or	CC	O	O
cold	cold	JJ	B-NP	O
intolerance	intolerance	NN	I-NP	O
,	,	,	O	O
fevers	fever	NNS	B-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
dysuria	dysuria	NN	B-NP	O
,	,	,	O	O
weight	weight	NN	B-NP	O
loss	loss	NN	I-NP	O
,	,	,	O	O
cough	cough	NN	B-NP	O
,	,	,	O	O
hemoptysis	hemoptysis	NN	B-NP	O
,	,	,	O	O
diplopia	diplopia	NN	B-NP	O
,	,	,	O	O
weakness	weakness	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
numbness	numbness	NN	B-NP	O
.	.	.	O	O

PEX	PEX	NN	B-NP	B-protein
:	:	:	O	O
bp	bp	NN	B-NP	O
120/62	120/62	CD	B-NP	O
82	82	CD	I-NP	O
95	95	CD	I-NP	O
%	%	NN	I-NP	O
ra	ra	NN	I-NP	O
GEN	GEN	NN	I-NP	O
:	:	:	O	O
wn/wd	wn/wd	VB	B-VP	O
adult	adult	JJ	B-NP	O
female	female	JJ	I-NP	O
nad	nad	NN	I-NP	O
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
has	have	VBZ	B-VP	O
systolic	systolic	JJ	B-NP	O
ejection	ejection	NN	I-NP	O
murmur	murmur	NN	I-NP	O
,	,	,	O	O
II/VI	II/VI	NN	B-NP	O
.	.	.	O	O

CHEST	CHEST	NN	B-NP	O
:	:	:	O	O
lungs	lung	NNS	B-NP	O
clear	clear	VBP	B-VP	O
.	.	.	O	O

ABD	ABD	NN	B-NP	O
:	:	:	O	O
benign	benign	JJ	B-NP	O
LABS	LABS	NN	I-NP	O
:	:	:	O	O
ETT	ETT	NNP	B-NP	O
MIBI	MIBI	NNP	I-NP	O
:	:	:	O	O
small	small	JJ	B-NP	O
fixed	fix	VBN	I-NP	O
inferior	inferior	JJ	I-NP	O
septal	septal	JJ	I-NP	O
defect	defect	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
inducible	inducible	JJ	I-NP	O
ischemia	ischemia	NN	I-NP	O
at	at	IN	B-PP	O
low	low	JJ	B-NP	O
workload	workload	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
4	4	CD	B-NP	O
minutes	minute	NNS	I-NP	O
or	or	CC	O	O
ETT	ETT	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

CXR	CXR	NN	B-NP	B-protein
:	:	:	O	O
suggestion	suggestion	NN	B-NP	O
of	of	IN	B-PP	O
early	early	JJ	B-NP	O
CHF	CHF	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
other	other	JJ	I-NP	O
abnormality	abnormality	NN	I-NP	O
.	.	.	O	O

KUB	KUB	NN	B-NP	B-protein
:	:	:	O	O
unremarkable	unremarkable	JJ	B-ADJP	O
.	.	.	O	O

TROPONIN	TROPONIN	NN	B-NP	O
PEAK	PEAK	NN	I-NP	O
:	:	:	O	O
42	42	CD	B-NP	O
EKG	EKG	NN	I-NP	O
:	:	:	O	O
RIGHT	RIGHT	NN	B-NP	B-protein
BUNDLE	BUNDLE	NN	I-NP	I-protein
BRANCH	BRANCH	NN	I-NP	I-protein
BLOCK	BLOCK	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	O
new	new	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

CATH	CATH	NN	B-NP	B-protein
detailed	detail	VBD	B-VP	O
above	above	RB	B-ADVP	O
.	.	.	O	O

*****	*****	SYM	O	B-cell_type
HOSPITAL	HOSPITAL	NN	B-NP	I-cell_type
COURSE	COURSE	NN	I-NP	I-cell_type
*****	*****	SYM	B-NP	I-cell_type
see	see	VBP	B-VP	O
above	above	IN	B-PP	O
for	for	IN	B-PP	O
complete	complete	JJ	B-NP	O
details	detail	NNS	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
acute	acute	JJ	B-NP	O
non-qwave	non-qwave	JJ	I-NP	O
mi	mi	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
taken	take	VBN	B-VP	O
to	to	TO	B-PP	O
cardiac	cardiac	JJ	B-NP	B-protein
cath	cath	NN	I-NP	I-protein
lab	lab	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
details	detail	NNS	I-NP	I-protein
above	above	IN	B-PP	I-protein
-RRB-	-RRB-	NN	B-NP	I-protein
.	.	.	O	O

Her	Her	PRP$	B-NP	O
tight	tight	JJ	I-NP	O
RCA	RCA	NN	I-NP	O
and	and	CC	I-NP	O
PDA	PDA	NN	I-NP	O
lesions	lesion	NNS	I-NP	O
were	be	VBD	B-VP	O
intervened	intervene	VBN	I-VP	O
upon	upon	IN	B-PP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
occasional	occasional	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
and	and	CC	O	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
request	request	VB	I-VP	O
DILAUDID	DILAUDID	NN	B-NP	O
-	-	HYPH	B-NP	O
CLEARLY	CLEARLY	NN	I-NP	O
NARCOTIC	NARCOTIC	NN	I-NP	O
SEEKING	SEEKING	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
ETT-MIBI	ETT-MIBI	NN	I-NP	B-DNA
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Further	Further	JJ	B-NP	O
enzymatic	enzymatic	JJ	I-NP	O
studies	study	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
transaminitis	transaminitis	NN	B-NP	O
,	,	,	O	O
pancreatitis	pancreatitis	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
obstructive	obstructive	JJ	B-NP	O
biliary	biliary	JJ	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Underwent	Underwent	JJ	B-NP	O
dialysis	dialysis	NN	I-NP	O
twice	twice	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
this	this	DT	B-NP	O
relieved	relieve	VBN	B-VP	O
many	many	JJ	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
somatic	somatic	JJ	I-NP	O
complaints	complaint	NNS	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
home	home	NN	B-ADVP	O
in	in	IN	B-PP	O
good	good	JJ	B-NP	O
condition	condition	NN	I-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
NQWMI	NQWMI	NN	I-NP	O
with	with	IN	B-PP	O
percutaneous	percutaneous	JJ	B-NP	O
intervention	intervention	NN	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
PAGE	PAGE	NN	B-NP	B-DNA
1	1	CD	I-NP	I-DNA
VNA	VNA	NN	I-NP	I-DNA
INSTRUCTIONS	INSTRUCTIONS	NNS	I-NP	I-DNA
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
see	see	VB	B-VP	O
Ms.	Ms.	NNP	B-NP	O
Noh	Noh	NNP	I-NP	O
for	for	IN	B-PP	O
home	home	NN	B-NP	O
safety	safety	NN	I-NP	O
eval	eval	NN	I-NP	O
,	,	,	O	O
medication	medication	NN	B-NP	O
review	review	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
medical	medical	JJ	B-NP	O
follow-up	follow-up	NN	I-NP	O
.	.	.	O	O

Please	Please	NN	B-NP	O
followup	followup	NN	I-NP	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
doctor	doctor	NN	I-NP	O
and	and	CC	I-NP	O
cardiologist	cardiologist	NN	I-NP	O
within	within	IN	B-PP	O
2	2	CD	B-NP	O
and	and	CC	I-NP	O
four	four	CD	I-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
have	have	VBP	B-VP	O
had	have	VBN	I-VP	O
a	a	DT	B-NP	O
heart	heart	NN	I-NP	O
attack	attack	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
must	must	MD	B-VP	O
be	be	VB	I-VP	O
sure	sure	JJ	B-ADJP	O
to	to	TO	B-VP	O
see	see	VB	I-VP	O
your	your	PRP$	B-NP	O
doctors	doctor	NNS	I-NP	O
regularly	regularly	RB	B-ADVP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
seek	seek	VB	I-VP	O
medical	medical	JJ	B-NP	O
attention	attention	NN	I-NP	O
immediately	immediately	RB	B-ADVP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
should	should	MD	B-VP	O
have	have	VB	I-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
dizziness/loss	dizziness/loss	NN	B-NP	O
of	of	IN	B-PP	O
consciousness	consciousness	NN	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
ENTERED	ENTERED	JJ	B-NP	O
BY	BY	NN	I-NP	O
:	:	:	O	O
REMONDET	REMONDET	NNP	B-NP	O
,	,	,	O	O
ALPHONSE	ALPHONSE	NNP	B-NP	O
S.	S.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
LA93	LA93	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
8/6/01	8/6/01	CD	I-NP	O
@	@	NN	I-NP	O
03	03	CD	I-NP	O
:	:	:	O	O
53	53	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

